Navigation Links
Cynosure Announces Upcoming Conference Presentations
Date:8/28/2012

WESTFORD, Mass., Aug. 28, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that management will be presenting at two upcoming investor conferences.

  • On Tuesday, September 11 at 10:25 a.m. (ET), President and Chief Executive Officer Michael Davin and Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at the Rodman & Renshaw Annual Global Investment Conference in New York City.
  • On Thursday, September 20 at 3:30 p.m. (ET), Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at the UBS Global Life Sciences Conference in New York City.

To access the live or archived webcasts of these events, visit the "Investor Relations" portion of Cynosure's website, www.cynosure.com.

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Contact:

Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com

 


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Receives FDA Clearance for At-Home Device for the Treatment of Wrinkles
2. Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director
3. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
4. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
5. Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date
6. InterMune Announces Presentations of New Research in IPF at ERS
7. MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
8. West Physics Consulting Announces Radiation Dose Reduction Services For CT, Fluoroscopy And Other Modalities
9. CLEANPATH RESOURCES CORP Announces Next Generation of Four Herbal Products
10. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
11. WorkSmart MD Announces Expansion of its Synergy Billing Division to Help Community Health Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)...  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" ... of its issued and outstanding shares of common stock ... 11, 2016. The Company,s common stock will trade on ... temporary ticker symbol "RCHAD". After 20 trading days, the ... (RCHA).  --> --> ...
(Date:2/10/2016)... , Feb. 10, 2016  The ... Nursing received an in-kind gift from ... a VeinViewer® Vision vein finder for the ... help students as they learn how to ... technology with traditional technique. ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... its growing list of Partner Firms. S.S. Nesbitt is headquartered in Birmingham, ... and in between. , Harnessing the experience and insights of the agency’s team ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... For additional ... new book , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" ... can improve memory. The book’s publication date is March 16, 2016. A ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable ... find and select appointments via Everseat’s free mobile app. , The partnership gives ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Workrite Ergonomics this ... versatile series of monitor mounts ever. , “Our goal was to develop a ... to install system that we have ever created.” said Darren Hulsey, Product Manager for ...
Breaking Medicine News(10 mins):